◀ Back to MYLIP

MEF2C — MYLIP

Text-mined interactions from Literome

Granjon et al., Diabetes 2009 (Diabetes Mellitus, Type 2...) : We further demonstrated that sterol regulatory element binding protein ( SREBP)-1c and myocyte enhancer factor 2C were involved in the effect of insulin on miR-1 and miR-133a expression
Lu et al., Cardiovasc Res 2010 (Diabetes Mellitus, Type 2...) : Using in silico miRNA target prediction programs, we prioritized candidate miR-223 target genes, but observed no effect of miR-223 on myocyte enhancer factor 2c or insulin-like growth factor 1 receptor, and an unexpected miR-223 induced increase in nuclear factor IA
Wilson et al., Circulation. Cardiovascular genetics 2010 : Overexpression of miR-499 and -1 resulted in upregulation of important cardiac myosin heavy-chain genes in embryoid bodies ; miR-499 overexpression also caused upregulation of the cardiac transcription factor MEF2C
Shen et al., Am J Pathol 2011 (Hypertrophy...) : Overexpression of miR-373 decreased the cell size, and also reduced the level of its target gene MEF2C , and miR-373 expression was regulated by p38
Cesana et al., Cell 2011 (Muscular Dystrophy, Duchenne) : We show that linc-MD1 `` sponges '' miR-133 and miR-133 [ corrected ] to regulate the expression of MAML1 and MEF2C , transcription factors that activate muscle-specific gene expression
Kornfeld et al., Nat Cell Biol 2012 : Adrenergic stimulation inhibits expression of miR-133a/b in a Mef2c dependent manner to abrogate post-transcriptional silencing of Prdm16